uk.investing.com on MSN1h
Moderna stock climbs as HSBC upgrades to Buy on underestimated pipeline potentialShares in biotech firm Moderna (NASDAQ:MRNA) rose more than 4% Monday after HSBC (LON:HSBA) raised its rating on the stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback